Skip to main content

Advertisement

Log in

Modeling and simulation of the modified Rankin Scale and National Institutes of Health Stroke Scale neurological endpoints in intracerebral hemorrhage

  • Original Paper
  • Published:
Journal of Pharmacokinetics and Pharmacodynamics Aims and scope Submit manuscript

Abstract

Intracerebral hemorrhage (ICH) is a form of stroke characterized by uncontrolled bleeding into the parenchyma of the brain. There is no approved therapy for ICH and it is associated with very poor neurological outcomes with around half of subjects dying within 1 month and most subjects showing complete or partial disability. A key challenge is to identify subjects who could benefit from intervention using characteristics such as baseline hemorrhage volume and the increase in hemorrhage volume in the first few hours, which have been correlated with final outcomes in ICH. Combined longitudinal models were developed to describe stroke scales using categorical data (Modified Rankin Scale, mRS), continuous bounded data (National Institutes of Health Stroke Scale, NIHSS), and time to death. Covariate effects for baseline hematoma volume and maximum increase in hematoma volume were incorporated to assess the improvement in outcome when hematoma volume increase would be reduced by a potential treatment. The combined model provided an adequate description of stroke scales, with patients split into a Non-survival and a High-survival sub-population, and dropout due to death was well described by a constant hazard survival model. Models were compared indicating that the combined mRS/NIHSS model provided the most information, followed by the NIHSS-only model, and the mRS-only model, and finally the traditional statistical analysis on dichotomized response at 90 days. Simulations showed that substantial reductions in hematoma volume increase were required to increase the probability of a favorable outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Broderick J et al (2007) Guidelines for the management of spontaneous intracerebral hemorrhage in adults 2007 update. Stroke 38:2001–2023

    Article  Google Scholar 

  2. Mozaffarian D et al (2015) Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 131:e29–e322

    PubMed  Google Scholar 

  3. Mayer SA et al (2008) Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 358:2127–2137

    Article  CAS  Google Scholar 

  4. http://www.virtualtrialsarchive.org/vista-ich/. Accessed 17 July 2018

  5. Lynden P (2017) Using the National Institutes of Health Stroke Scale, A Cautionary tale. Stroke 48:513–519

    Article  Google Scholar 

  6. https://stroke.nih.gov/documents/NIH_Stroke_Scale.pdf. Accessed 17 July 2018

  7. Banks JL, Marotta CA (2007) Outcomes validity and reliability of the modified rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 38:1091–1096

    Article  Google Scholar 

  8. mRS. http://rankinscale.org/. Accessed 25 May 2016

  9. Sheiner LB (1994) A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data. Clin Pharmacol Ther 56:309–322

    Article  CAS  Google Scholar 

  10. Beal SL, Sheiner LB, Boeckmann AJ, Bauer RJ (Eds) (1989–2011) NONMEM users guides. Icon Development Solutions, Ellicott City

  11. Lindbom L, Pihlgren P, Jonsson EN (2005) PsN-toolkit—a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Progr Biomed 79:241–257

    Article  Google Scholar 

  12. R Development Core Team (2015) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna

    Google Scholar 

  13. Karlsson MO, Holford N (2008) A tutorial on visual predictive checks. PAGE 17:1434

    Google Scholar 

  14. Ueckert S, Karlsson MO, Hooker AC (2016) Accelerating Monte-Carlo power studies through parametric power estimation. J Pharmacokinet Pharmacodyn 43:223–234

    Article  Google Scholar 

  15. Bruno A et al (2011) Simplified modified rankin scale questionnaire. Reproducibility over the telephone and validation with quality of life. Stroke 42:2276–2279

    Article  Google Scholar 

  16. Savio K et al (2013) Reliability of the modified Rankin Scale applied by telephone. Neurol Int 5:e2

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Bill Denney for his valuable input in early stages of model development. VISTA-ICH Steering Committee: Daniel F. Hanley (Chair), Kenneth S. Butcher, Stephen Davis, Barbara Gregson, Kennedy R. Lees, Patrick Lyden, Stephan Mayer, Keith Muir and Thorsten Steiner.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

RS, SN, LH, and MOK wrote the manuscript; RS modelled the data.

Corresponding author

Correspondence to Lutz O. Harnisch.

Ethics declarations

Conflict of interest

At the time this manuscript was submitted for publication, L.H. and S.N were full-time employees of Pfizer Ltd, and R.S and M.O.K. were paid consultants for Pfizer Ltd.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The VISTA-ICH Steering Committee are listed in “Acknowledgements”.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 671 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schoemaker, R., Nayak, S., Harnisch, L.O. et al. Modeling and simulation of the modified Rankin Scale and National Institutes of Health Stroke Scale neurological endpoints in intracerebral hemorrhage. J Pharmacokinet Pharmacodyn 46, 473–484 (2019). https://doi.org/10.1007/s10928-019-09653-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10928-019-09653-4

Keywords

Navigation